Physician
Gastroenterology
Dr. Robert P. Perrillo, MD
|
|
Give Review
Dr. Robert P. Perrillo works in the field of Gastroenterology. He studied medicine at Georgetown University School of Medicine. Georgetown University School of Medicine is ranked 49 in research and 84 in primary care medicine He received 1 awards: "Regional Top Doctor". Dr. Robert P. Perrillo is a published physician. He published 97 publications, including: 'Association of diabetes mellitus and chronic hepatitis C virus infection.' Robert Perrillo is registered with Medicare and accepts Medicare payments.
Publications
- Preventing Hepatitis B Reactivation Due to Immunosuppressive Drug Treatments.
- American gastroenterological association institute technical review on prevention and treatment of Hepatitis B virus reactivation during immunosuppressive drug therapy.
- Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and HBV Genotype.
- Psoriasis, Hepatitis B, and the tumor necrosis factor-alpha inhibitory agents: A review and recommendations for management.
- Extended treatment with lamivudine and adefovir dipivoxil in chronic Hepatitis B patients with lamivudine resistance.
- Withholding statins in patients with underlying liver disease: wise or unwise?
- Entering the new era of therapy for HBV and HCV infections.
- Hepatitis B surface antigen quantification as a current-day paradox: obtaining the gold in the face of diminishing returns.
- Halting the natural history of Hepatitis B viral infection: a paradigm shift.
- Customizing the management of chronic Hepatitis B virus infection.
- Comparison of clinical outcomes in chronic Hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
- Therapy of Hepatitis B -- viral suppression or eradication?
- Chronic Hepatitis B: a critical appraisal of current approaches to therapy.
- The use of HBsAg-positive organ donors: far more than meets the eye?
- Current treatment of chronic Hepatitis B: benefits and limitations.
- Overview of treatment of Hepatitis B: key approaches and clinical challenges.
- Hepatitis B virus genotypes in the United States: results of a nationwide study.
- Hepatitis B and renal transplantation: securing the sword of damocles.
- Determinants of early mortality in patients with decompensated chronic Hepatitis B treated with antiviral therapy.
- Is obesity an independent risk factor for hepatocellular carcinoma in Cirrhosis?
- Predictors of HBeAg loss after lamivudine treatment for chronic Hepatitis B.
- How will we use the new antiviral agents for Hepatitis B?
- Serum and liver Hepatitis B virus DNA in chronic Hepatitis B after sustained loss of surface antigen.
- Relationship between histology, aminotransferase levels, and viral replication in chronic Hepatitis B.
- Type A and type B attentional Responses to aesthetic stimuli: effects on mood and performance.
- Effect of pancreatic proteases on intestinal lactase activity.
- The relationship of Hepatitis B e antigen, DNA polymerase activity, and titer of Hepatitis B surface antigen with ongoing liver injury in chronic Hepatitis B virus inf...
- Low-dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with Hepatitis B virus.
- Monitoring of antiviral therapy with quantitative evaluation of HBeAg: a comparison with HBV DNA testing.
- Hepatitis B virus replication in diverse cell types during chronic Hepatitis B virus infection.
- Selective outpatient management of upper gastrointestinal bleeding in the elderly.
- Multicenter study of lamivudine therapy for Hepatitis B after liver transplantation. Lamivudine Transplant Group.
- Prevalence of herpesviridae and Hepatitis B virus DNA in the liver of patients with non-A, non-B fulminant hepatic failure.
- Adefovir dipivoxil for the treatment of lamivudine-resistant Hepatitis B mutants.
- Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic Hepatitis C.
- Transcription-mediated amplification is more sensitive than conventional PCR-based assays for detecting residual serum HCV RNA at end of treatment.
- Hepatitis C RNA in liver of chronic Hepatitis C patients before and after interferon alfa treatment.
- Clinical utility of viral load measurements in individuals with chronic Hepatitis C infection on antiviral therapy.
- Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribavirin as...
- Challenges and opportunities for medical education and clinical research in a changing healthcare environment.
- Initial evaluation of repeatable serum aminotransferase abnormalities.
- Selective Outpatient Management of Upper Gastrointestinal Bleeding in the Elderly: Results from the SOME Bleeding Study.
- Multicenter studies of Lamivudine for the treatment and prevention of Hepatitis B after liver transplantation.
- Editorial: Measurement of HBsAg concentration during antiviral therapy of Hepatitis B: who, when, and why.
- Chronic Hepatitis B infection: A workshop consensus statement and algorithm.
- Patient management and clinical decision making in HBV--aims of therapy and what we can achieve.
- From the Editor's Desk: West Nile Virus in the US: There Goes the Neighborhood.
- Benefits and risks of interferon therapy for Hepatitis B.
- Hepatitis B virus prevention strategies for antibody to Hepatitis B core antigen-positive liver donation: a survey of North American, European, and Asian-Pacific trans...
- Impact of the Hepatitis B virus genotype on pre- and post-liver transplantation outcomes.
- Hepatitis B: reflections on the current approach to antiviral therapy.
- A pilot study of extended duration peginterferon alfa-2a for patients with Hepatitis B e antigen-negative chronic Hepatitis B.
- Adefovir dipivoxil added to ongoing lamivudine in chronic Hepatitis B with YMDD mutant Hepatitis B virus.
- Allograft transmission of Hepatitis C virus infection from infected donors in cardiac transplantation.
- Management of chronic Hepatitis B virus infection: current perspectives for the nurse practitioner.
- Hepatitis B virus replication x time equals trouble.
- Hepatitis B virus replication in damaged endothelial tissues of patients with extrahepatic disease.
- Acute autoimmune Hepatitis presenting with centrizonal liver disease: case report and review of the literature.
- Lamivudine as initial treatment for chronic Hepatitis B in the United States.
- The roles of amantadine, rimantadine, ursodeoxycholic acid, and NSAIDs, alone or in combination with alpha interferons, in the treatment of chronic Hepatitis C.
- Response to higher doses of interferon alfa-2b in patients with chronic Hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy Group.
- Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B Hepatitis (Hepatitis C). The Hepatitis Interventional T...
- Hepatitis and cholestasis in a middle-aged woman.
- Prolonged survival in fibrosing cholestatic Hepatitis with long-term ganciclovir therapy.
- Increased hepatocyte expression of Hepatitis B virus transcription in patients with features of fibrosing cholestatic Hepatitis.
- Antiviral therapy of chronic Hepatitis B: past, present, and future.
- Association of diabetes mellitus and chronic Hepatitis C virus infection.
- Molecular basis for persistent Hepatitis B virus infection in the liver after clearance of serum Hepatitis B surface antigen.
- Treatment of posttransplantation Hepatitis B.
- The A to Z of new hepatotropic agents: human Hepatitis viruses and monkey business.
- The role of liver biopsy in Hepatitis C.
- Comparison of quantitative HCV RNA assays in chronic Hepatitis C.
- Morbidity of chronic Hepatitis C as seen in a tertiary care medical center.
- Interferon for Hepatitis B: US experience.
- Hepatitis B: transmission and natural history.
- Hepatitis B and liver transplantation. Problems and promises.
- Quantitative detection of Hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical a...
- The management of chronic Hepatitis B.
- Assessing health-related quality of life in chronic Hepatitis C using the Sickness Impact Profile.
- Application of six Hepatitis C virus genotyping systems to sera from chronic Hepatitis C patients in the United States.
- Genomic variations in the Hepatitis B core gene: a possible factor influencing response to interferon alfa treatment.
- Viral Hepatitis management. Standards for the future. Case studies.
- Chronic Hepatitis B: problem patients (including patients with decompensated disease).
- Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay.
- Therapy for Hepatitis B virus infection.
- A preliminary trial of lamivudine for chronic Hepatitis B infection.
- Complementary use of computerized tomography and technetium scanning in the diagnosis of accessory spleen.
- Quantitative temporal analysis of 99mTechnetium p-isopropyl-iminodiacetic acid (PIPIDA) as a measure of hepatic function in health and disease.
- The clinical course and chronic sequelae of Hepatitis B virus infection.
- Should spouses of Hepatitis B surface antigen carriers receive Hepatitis vaccine?
- Survey of Hepatitis B viral markers at a public day school and a residential institution sharing mentally handicapped students.
- Spontaneous clearance and reactivation of Hepatitis B virus infection among male homosexuals with chronic type B Hepatitis.
- Acute non-A, non-B hepatitis with serum sickness-like syndrome and aplastic Anemia.
- Anti-Hepatitis B core immunoglobulin M in the serologic evaluation of Hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B...
- A problem with a severed feeding tube.
- Immune globulin and Hepatitis B immune globulin. Prophylactic measures for intimate contacts exposed to acute type B Hepatitis.
Procedures Preformed
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Cholecystitis and Gallstones
- Cirrhosis
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Washington University - Barnes-Jewish Hospital -
Nassau University Medical Center -
Georgetown University School of Medicine
Hospital
-
Baylor University Medical Center
Drug Facts
| NPI NUMBER | 1316962327 | |
| NPPES Provider LastName | PERRILLO | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 75246 | |
| NPPES Provider State | TX | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 99.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1316962327 |
| Last Name Of The Provider | PERRILLO |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Roopa Vemulapalli, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clement R. Boland Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacqueline G. O'Leary, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Linda A. Feagins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stuart J. Spechler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel C. Demarco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John S. Fordtran, MD
This Doctor is OpenDoctor Recommended.
|